Established in 2019, Sonder Research X is a Weill Cornell Medical School spin-off company focused on using advanced imaging ...
Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for ...